Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	8.58	85.19	78.46
Graham Fair Price	3.25	2.90	2.81
PEG	inf	0.00	1.02
Price/Book	3.40	11.12	10.75
Price/Cash Flow	-52.22	134.23	280.95
Prices/Earnings	9.51	32.07	29.28
Price/Sales	10.14	45.49	41.30
Price/FCF	-52.22	134.23	280.95
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	2.52	0.70	0.68
Operating Margin	2.30	0.45	0.44
ROA	-2.53	0.05	0.05
ROE	0.09	0.09	-5.58
ROIC	0.07	0.07	-0.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.10	0.47	-79.45
Dividends QOQ	0.10	< 0.005	-99.78
EBIT QOQ	0.26	0.02	-92.07
EPS QOQ	0.29	0.00	inf
FCF QOQ	-0.46	1.30	181.87
Revenue QOQ	0.24	< 0.005	-98.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.41	6.34	-14.38
Days Sales Outstanding (DSO)	62.15	64.06	3.07
Inventory Turnover	12.15	14.19	16.79
Debt/Capitalization	0.27	0.24	-11.32
Quick Ratio	1.02	1.05	2.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	1.96	2.08	6.26
Cash	0.66	0.66	-1.18
Capex	-0.08	-0.09	-12.52
Free Cash Flow	0.07	0.17	129.96
Revenue	0.51	0.51	-0.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.22	1.24	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.12	1.79	-15.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating